Gayatri BioOrganics Ltd

Gayatri BioOrga has faced significant financial challenges, reporting minimal revenue and consistent losses, with net sales dropping to zero in 2024 and 2025, and negative reserves of -114.68 Cr by March 2025. The company has not generated any cash flow from operations since March 2020.

Gayatri BioOrga has faced persistent financial challenges, with stagnant revenues, consistent losses, and negative shareholder funds, culminating in a significant loss of -1.01 crore in March 2023. The company's financial position has deteriorated, showing no operational activity over the last three years.

As of 24-Sep, Gayatri BioOrganics Ltd's stock price is declining at 11.83, down 3.11% today, with a total loss of 4.9% over the last two days. Despite strong long-term returns, recent performance shows decreased investor participation and a negative trend compared to benchmarks.

As of 23-Sep, Gayatri BioOrganics Ltd is priced at 12.26, down 1.45%. Despite a year-to-date return of 77.17%, recent declines indicate potential profit-taking and reduced investor interest, with a significant drop in delivery volume.

As of 22-Sep, Gayatri BioOrganics Ltd's stock price is at 12.44, having increased by 1.63% recently. Despite strong performance and significant year-to-date gains, declining investor participation may pose risks to its upward momentum.

As of 19-Sep, Gayatri BioOrganics Ltd is experiencing a price increase to 12.24, reflecting a 4.35% upward change. Despite strong short-term performance and significant annual returns, the stock's high volatility and weak long-term fundamentals raise concerns about its sustainability.

As of 18-Sep, Gayatri BioOrganics Ltd's stock price is declining at 11.73, down 2.57%, and underperforming its sector. Despite strong annual returns, the company faces significant challenges, including high debt and negative profitability, leading to decreased investor interest.

As of 17-Sep, Gayatri BioOrganics Ltd is experiencing a price increase to 12.04, reflecting a 2.29% rise. The stock shows strong upward momentum and significant investor participation, but faces risks due to negative book value and high debt levels.

As of 16-Sep, Gayatri BioOrganics Ltd's stock price is declining at 11.77, down 3.37%, with a total drop of 3.45% over the last two days. Despite strong year-to-date and one-year returns, weak fundamentals and declining investor interest are driving the recent downturn.

As of 15-Sep, Gayatri BioOrganics Ltd is priced at 12.18, down 0.08%, and has underperformed its sector today. Despite a strong monthly return of 6.84% and a year-to-date increase of 76.01%, recent declines in investor participation and a trend reversal may indicate reduced buying interest.

As of 12-Sep, Gayatri BioOrganics Ltd is priced at 12.19, reflecting a recent positive trend with a total return of 4.1% over three days. Despite strong short-term performance and impressive year-to-date returns, the company faces significant financial challenges that may deter investors.

As of 11-Sep, Gayatri BioOrganics Ltd is priced at 12.00, with a recent increase of 2.04% and strong year-to-date returns of 73.41%. However, declining investor participation and underlying financial weaknesses raise concerns about its long-term viability despite short-term gains.

As of 10-Sep, Gayatri BioOrganics Ltd is priced at 11.76, showing a slight increase but facing a 2.00% decline over the past week amid reduced investor participation and financial challenges. Despite a strong year-to-date return of 69.94%, the stock's high debt and negative book value raise concerns about its long-term stability.

As of 09-Sep, Gayatri BioOrganics Ltd's stock price is declining at 11.71, down 3.62%, despite a strong year-to-date return of 69.22%. Recent financial challenges, including negative book value and weak earnings, have raised investor concerns, leading to short-term underperformance against the market.

As of 08-Sep, Gayatri BioOrganics Ltd is currently priced at 12.15, reflecting a 1.0% increase and a year-to-date return of 75.58%. Despite recent gains, the company has a negative book value and weak fundamentals, which may raise investor caution.

As of 05-Sep, Gayatri BioOrganics Ltd is seeing a price increase to 12.03, with a 21.03% return over the past month, significantly outperforming the flat Sensex. Despite some short-term fluctuations, the stock's year-to-date return of 73.84% and one-year return of 104.59% indicate strong overall performance compared to the broader market.